Events

On this page you will find Upcoming and Past Events. Enjoy reading and researching.

Upcoming Events

• 7 - 11 November 2025

  The Liver Meeting 2025

  Read more

  Mark your calendars! The 2025 Liver Meeting is set to take place from November 7–11, 2025, in Washington, DC, USA. Save the date!

  Congress website
• 4 - 7 October 2025

  UEG Week 2025

  Read more

  The UEG Week is coming to Berlin, Germany, from 4 - 7 October 2025. Don't miss it!

  Congress website
• 7 - 10 May 2025

  DECISION at EASL Congress 2025

  Read more

  We're excited that DECISION will once more join the prestigious EASL Congress in May 2025. Grab your calendars and save-the-date for our networking session at Cirrhosis and Complications Track Hub!
  When? Friday 9^th May, 10:15 – 10:45 am
  Where? Cirrhosis & Complications Track Hub
  What? Look forward to a compelling program we'll share in due time.

  Visit the congress website

Past Events

• 21 October 2024

  This was our 6th General Assembly Meeting

  Read more

  The DECISION project held its 6th General Assembly from October 16–18, 2024, in Bologna, Italy, focusing on novel therapies, biomarker validation, and clinical translation for acutely decompensated cirrhosis.

  Scientific Highlights:

  • Epigenetics and Transcriptomics: Estefania Huergo presented on epigenetic signatures, while Richard Moreau highlighted RNA-sequencing data, both offering insights into predicting adverse outcomes and mortality risks.
  • Biomarker Discovery: Johanna Reissing and Cristina López-Vicario identified potential biomarkers like microRNAs and inflammatory proteins linked to disease progression and ACLF risk. Pierre-Emmanuel Rautou discussed extracellular vesicles and their correlation with mortality.
  • Preclinical Models: Frank Uschner showcased progress in preclinical models testing combinatorial therapies like albumin and enoxaparin for ACLF.
  • Patient Stratification: David Gomez-Cabrero reported advancements in predicting outcomes using multi-omics data.
  • Clinical Trials: Paolo Caraceni outlined the COMBAT trial, assessing a combinatorial therapy, and the PROSPECT study focusing on biomarker validation and survival prediction.

  Outreach and Impact: Tamara Berghammer emphasized dissemination efforts through a dedicated website, social media, and conference participation, ensuring the project’s influence and visibility.

  The assembly concluded with a summary of progress in identifying new therapeutic strategies for liver disease, underscoring the consortium’s dedication to translating research into clinical practice.

  Article is adapted from the EF-CLIF's news piece here.

• 16 - 18 October 2024

  Looking forward to our 6th General Assembly!

  Read more

  We're excited to gather for our sixth General Assembly Meeting in Bologna, Italy, from 16th to 18th October 2024.

  This year’s highlights include a keynote lecture on Inflammation in Acute Decompensation (AD) of Cirrhosis and Acute-on-Chronic Liver Failure (ACLF), presented by Richard Moreau, Director of EF CLIF. Additionally, don’t miss the masterclass on Clinical Bioinformatics, led by David Gomez Cabrero, Cristina Sanchez, and Nuria Planell Picola.

• 5 - 8 June 2024

  DECISION at EASL Congress 2024

  Read more

  What a blast! DECISION members have been super active at this year's EASL Congress 2024 in Milan, Italy. A highlight definitely was our networking event on 5th June 2024, with a packed cirrhosis and complications track hub.

  

  

  

  

  

• 18 - 19 April 2024

  Upcoming: DECISION’s 9th Steering Committee Meeting

  Read more

  Our 9th Steering Committee (SC) Meeting will take place in beautiful Münster, Germany, hosted by our partner, the Münster University Hospital. During the 1.5 meeting days, we'll be discussing the project's progress, its achievements so far, and plan ahead for the next months to come.

• 18 - 20 October, 2023

  5th General Assembly Meeting in Padova, Italy

  Read more

  Members of the DECISION Consortium met in Padova, Italy, to discuss recent research results in preparation of several manuscripts shedding some new light on the pathophysiology of acute decompensation of cirrhosis and development of acute-on-chronic liver failure (ACLF) – a syndrome associated with high short-term mortality. After three years of intensive work, the upcoming COMBAT trial will use newly identified biomarkers to predict disease progression and test safety and effectiveness of a combinatorial drug therapy.

  Originally published on the EF CLIF website.

  

• 10 - 14 November, 2023

  AASLD 2023 (cv-rg.com)

  Read more

  The Liver Meeting
  10-14 November 2023, Boston, USA

  Read More
• 14 - 17 October, 2023

  UEG Week 2023 – United European Gastroenterology

  Read more

  UEG Week 2023
  14-17 October 2023, Copenhagen, Denmark

  Registration still open.

  DECISION coordinator Prof. Pierre-Emmanuel Rautou will be speaking about "Anticoagulation in portal vein thrombosis" during thesession "Never waste a good disaster (Hepatobiliary and pancreas)" in Auditorium 10 on Monday, October 16, 10:00 - 11:00.

• 21 - 24 June, 2023

  DECISION at EASL Congress 2023

  Read more

  Join us for a DECISION and MICROB-PREDICT networking event on 21. June, 13.30-14.30h at the EASL Congress 2023 in Vienna, community hub. Learn about latest results and meet the team!

  Other opportunities to meet DECISION members at the congress:

  Thursday, 22. June 2023:

  • Pierre-Emmanuel and Virginia Hernandez-Gea (EASL) will chair the Research Think Tank: Vascular liver diseases beyond thrombosis (8:30-9:45 CET, room Lehar 4)
  • Sara Montagnese (UNIPD) will chair the Research Think Tank: Liver transplantation vs. alternative treatments in decompensated cirrhosis (8:30-9:45 CET, room Stolz 2)
  • Paolo Caraceni (UNIBO) will give a talk on “Preventing overt HE: long-term albumin as potential strategy” (12:45-13:45 CET)
  • Sophie Lotersztajn (INSERM) will host a State-of-the-art talk on "Stress response in Liver disease" (14:00-14:30 CET in the Auditorium)
  • There will be a roundtable on "The Future of Hepatology/Hepatologists: a mix of opportunities and threats" with Marko Korenjak (ELPA) from 15:00-16:00 CET, in room Lehar 3)
  • Pierre-Emmanuel will also give a talk titled "EVs, vectors of information between organs in liver diseases" (15:20-15:30, in room Lehar 1-2)

  Friday, 23. June 2023:

  • Richard Moreau (INSERM): "The importance of scientific misconduct in peer- review" (8:30-9:30 CET, Workshop room)
  • Javier Fernández (FCRB): Hospitalised decompensated cirrhosis patients at high risk of infection – should we start empirical antibiotics or watch and wait for culture results (17:33-17:45 CET, Hepatology Arena)

  Saturday, 24. June 2023:

  • Paolo Caraceni (UNIBO): “Systems medicine for identification of novel therapeutic strategies and biomarkers, insight from DECISION” (8:57-9:09 CET, Strauss 1 room)
  • Luis Téllez (SERMAS): The new diagnostic criteria of portopulmonary hypertension identify a group of patients with cirrhosis at high risk of death" (14:30-14:45 CET, Lehar 3)

• 29 - 30 March 2023

  7^th Steering Committee (SC) Meeting in Pamplona, Spain

  Read more

  Our 7th Steering Committee Meeting took place in Pamplona, Spain from 29 – 30 March, 2023. During the two days, work package leaders and members have presented and discussed their scientific data and the overall status of their work package.

  With fruitful discussions, the consortium solidified the path for the coming months with regard to paper writing and the COMBAT-trial.

• 6 March 2023

  Successful patient event on 6^th March

  Read more

  In this event organized by ELPA with the title ‘The COMBAT-trial: A novel COMBinATorial therapy with albumin and enoxaparin in patients with decompensated cirrhosis at high-risk of poor outcome.’ experts from DECISION explained the upcoming clinical trial to patient representatives. They discussed the recruitment process and what it means from an ethical perspective. Great interest was shown in the question how patient representatives and clinicians can work together to facilitate recruitment for this trial.

• 19 - 21 October 2022

  4th General Assembly (GA) meeting in Madrid

  Read more

  The 4th GA meeting of DECISION took place from 19-21 October 2022 in Madrid. The meeting was a great success with the first day devoted to paper writing: on that day, 12 meetings took place to discuss and progress on 7 different papers with more than 20 people. On the second day, we extensively discussed the specifics of our upcoming COMBAT-Trial as well as our brand new and refined animal models of ACLF. The third day was devoted to multi-omics analyses, bioinformatics and machine learning as well as an update on the newly developed tools and checklists for ethics and data protection and the health economics studies planned in DECISION. We thank our Scientific Advisory Board members for their valuable feedback to improve the quality of our studies.

• 21 - 23 September 2022

  14th International Meeting on Therapy in Liver Diseases

  Read more

  From 21-23 September 2022, the 14^th edition of the International Meeting on Therapy in Liver Diseases organised by the Liver Unit at Hospital Clinic of Barcelona will take place. The aim of the meeting is to highlight and discuss the latest advances in Clinical Hepatology to be applied in every day clinical practice.

  On Thursday, 22^nd September at 3.45 p.m., DECISION member, Paolo Caraceni, will give a talk on “Acute decompensation in 2022: what is mandatory in the first diagnostic workup?”

  Read More
• 4 - 8 November 2022

  MEET-THE-EXPERT Session 16 – “Extracellular vesicles in liver disease”

  Read more

  The AASLD (American Association for the Study of Liver Diseases) brings together clinicians, associates, and scientists from around the world to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field of hepatology.

  Prof. Pierre-Emmanuel Rautou will be one of the moderators of this event, on 6^th November 2022 (8.00 a.m. – 8.45 a.m.) in Washington, DC. So, don’t miss the chance to interact with him and many other leading hepatologists.

• 22 - 26 June 2022

  International Liver Congress (ILC), June 2022

  Read more

  SAVE THE DATE: The International Liver Congress (ILC) 2022 has been rescheduled to 22–26 June 2022 in London, UK. We are looking forward to Prof Pierre-Emmanuel Rautou’s presentation on "Prognostic biomarkers of non-malignant liver disease – leaving the biopsy behind" during the postgraduate course: "The future of clinical hepatology" on June 22, 2022.

  More information
• 24 June 2022

  Meet us at ILC2022 on 24/06/2022, 12-13h GMT!

  Read more

  Don`t miss the opportunity to meet the team and receive important information about the project at ILC2022 at the EASL Community Hub! Read more.

• 29 - 30 April 2022

  Université de Paris Conference, April 2022

  Read more

  The 2021 edition had to be cancelled due to the pandemic, but we are already looking forward to this year's EPU de Gastroentérologie et d’Hépatologie de l’Université de Paris from 29 - 30 April 2022 in Paris, France.

  At this year's conference, project coordinator Pierre-Emmanuel Rautou will give a presentation on the topic ‘Why is portal hypertension deleterious?’. Stay tuned!

  More information
• 13 April 2022

  EASL studio, April 2022

  Read more

  On April 13, 2022, project coordinator Pierre-Emmanuel Rautou is giving a talk about ‘Should anticoagulants be given to patients with cirrhosis to improve outcome?’ at the EASL studio. Click here for more EASL events.

• 24 March 2022

  5th Steering Committee (SC) Meeting successfully completed

  Read more

  Our 5th SC meeting, taking place from 23-24 March 2022 in Paris, France has been successfully completed.

• 28 January 2022

  DECISION members at Falk Symposium on Alcoholic Liver Disease

  Read more

  From 27-28 January 2022, consortium member Prof. Jonel Trebicka (GUF), who had co-organised the Falk Foundation online Symposium, served as chairman of Session II on "Alcoholic hepatitis, liver failure, and systemic disturbance" and the poster session, while Dr. Richard Moreau and Dr. Sophie Lotersztajn (both at INSERM) gave talks on novel research data and discussed alcoholic liver disease and liver failure as an ailment that disturbs biological communication in the entire body, including systemic inflammation.

• 10 September 2021

  3rd General Assembly Meeting successfully completed

  Read more

  During DECISION’s first ever hybrid-meeting, 34 participants gathered face-to-face from 8-10 September in sunny Castelldefels (Barcelona), Spain. Additionally, 20 participants joined us remotely via Zoom. Discussions on novel rat models and the clinical study, as well as a poster session for the Early Career Scientists, were only a few highlights. Thanks to the amazing work of all partners, the project is progressing well.

• 08 September 2021

  First MasterClass for Early Career Scientists

  Read more

  On 8^th September 2021, 29 participants of the DECISION Consortium attended the first MasterClass which was organized as part of the WP7 training programme before the start of the 3^rd General Assembly Meeting, in Barcelona, Spain.

  The MasterClass included two talks on “How to write a paper (focus on original and review articles)" by Dr. Paolo Angelo from the University of Padova and Prof. Dr. Jonel Trebicka from the Goethe-Universität Frankfurt am Main. For further information and to download the presentations, click here.

  Overall, the feedback was positive, and this format will be repeated again at future General Assembly meetings.

• 02 September 2021

  DECISION Symposium connected to EASL School on Hepatology 2021

  Read more

  Successful MICROB-PREDICT and DECISION – Online Symposium ‘Management of acute-on-chronic liver failure’ on Thursday, 2nd September 2021 from 12.30 - 16.30h CEST which was organised at the occasion of the EASL School of Hepatology.

  At this symposium, several experts of both project consortia presented recent advances in the fields of microbiome research and systems medicine, introduced the role of proteomics and metabolomics in hepatology and discussed treatment strategies and their mechanisms of action in acute-on-chronic liver failure.

  With almost 100 registered attendees and speakers from 37 countries our symposium was a great success and we would like to thank everyone for their participation and the lively discussions.

  Download presentations
• 23 - 26 June 2021

  Cirrhosis and complications track at ILC 2021 – Prof. Pierre-Emmanuel Rautou

  Read more

  At the International Liver Congress™ 2021, the cirrhosis and complications track presents an overview of the role of vessels in liver diseases. The track content will include not only the role of liver sinusoidal changes in liver disease progression, but also the management of portal and hepatic vein thrombosis and their complications. The management of complications of portal hypertension will also be addressed, including the place of transjugular intrahepatic portosystemic shunt (TIPS) and the management of patients with advanced cirrhosis and acute-on-chronic liver failure (ACLF).

• 23 - 26 June 2021

  DECISION at the International Liver Congress 2021!

  Read more

  SAVE THE DATE: ILC 2021 will take place from Wednesday to Saturday, 23–26 June. Register now and visit our DECISION booth. Click here for more information!

• 24 June 2021

  ILC 2021: Symposium „Old and new treatments for patients with advanced cirrhosis”

  Read more

  Very successful symposium on Thursday, 24th June 2021 from 14-15h CEST organised by members of DECISION in the frame of the virtual ILC congress. Topics included:
  
  Why and how to modulate the microbiome: example from MICROB-PREDICT study (Shawcross)

  Old drugs for novel treatment strategies (Posé)

  Human albumin: from established indications to novel perspectives (Caraceni)

  System medicine: is it the right track to personalized treatments: example from DECISION study? (Trebicka)

• 09 June 2021

  DECISION online educational event for patients and public on 9th June 2021!

  Read more

  SAVE THE DATE: We kindly invite you an online educational event about “Therapies for acute decompensation of cirrhosis and ACLF, research needs and future outlook”. Experts from three EU-funded research projects will give talks and answer questions. The event takes place ONLINE on Wednesday, June 9th, from 03.30 – 05.00 PM (CEST).

  View announcement and programme.
• 5-8 May 2021, ISTANBUL

  International Liver Transplantation Society (ILTS) Annual Congress

  Read more

  The 2021 Joint International Congress of ILTS, ELITA and LICAGE will take place from May 5 - 8, 2021 in Istanbul, Turkey.

  Read More
• 13-16 November 2020, ONLINE

  The Liver Meeting

  Read more

  The Liver Meeting® will take place from November 13 – 16, 2020. The Liver Meeting® is going digital!

  Read More
• 11-13 October 2020, ONLINE

  United European Gastroenterology (UEG) Week

  Read more

  UEG Week Virtual 2020 and Best of Postgraduate Teaching from UEG Week will take place digitally. They remain the premier venue for researches from across the globe to present their latest findings.

  Read More
• 31st August 2020, ONLINE

  1st DECISION and ELPA patient event

  Read more

  We kindly invite you to the 1st DECISION and ELPA patient event. Our first patient event takes place ONLINE on Monday, August 31st, from 16-17h (CEST). For questions and registration, please contact office@elpa.eu.

  View announcement and programme
• 29 August 2020

  1st Digital International Liver Congress (Digital ILC)

  Read more

  The 1st Digital International Liver Congress (Digital ILC, #ILC2020) took place from 27-29 August 2020. DECISION was represented with a virtual booth and several talks given by members.

  Read More
• 27-29 August 2020, ONLINE

  International Liver Congress (ILC) – ONLINE

  Read more

  The 1st Digital International Liver Congress (Digital ILC, #ILC2020) takes place from 27-29 August 2020. You can meet us here:

  • DECISION booth, entire duration, Thursday-Saturday
  • Live Session & Chat 1: Fri, Aug 28, 2020 10:00 AM - 10:30 AM (CEST)
  • Live Session & Chat 2: Sat, Aug 29, 2020 10:00 AM - 10:30 AM (CEST)

  Register for ILC and view the programme